Ophthalmic wound healing with aldose reductase inhibitors

Details Ophthalmic wound healing with aldose reductase inhibitors Ophthalmic wound healing with aldose reductase inhibitors

1986-01-07

1988-01-05

Schenkman, Leonard

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514376, 514389, 514409, 514866, A61K 3144

Patent

active

047177250

ABSTRACT:
Method of promoting healing of ocular wounds comprising the topical application of an aldose reductase inhibitor; compositions comprising such inhibitors are also disclosed.

REFERENCES:
patent: 3821383 (1974-06-01), Sestanj et al.
patent: 4117230 (1978-09-01), Sarges
patent: 4130714 (1978-12-01), Sarges
patent: 4181728 (1980-01-01), Sarges et al.
patent: 4436745 (1984-03-01), York, Jr.
patent: 4438272 (1984-03-01), York, Jr.
patent: 4537892 (1985-08-01), York, Jr.
patent: 4600717 (1986-07-01), York

Affiliated with

Also associated with

Rating

Ophthalmic wound healing with aldose reductase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ophthalmic wound healing with aldose reductase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ophthalmic wound healing with aldose reductase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-9277